These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Behavioral assessment of subtle drug abstinence effects: overview and discussion. Brady JV NIDA Res Monogr; 1989; 95():131-4. PubMed ID: 2640963 [No Abstract] [Full Text] [Related]
4. [Symptom complex developing after the withdrawal of psychotropic drugs]. Perényi A Orv Hetil; 1983 May; 124(18):1073-4. PubMed ID: 6866507 [No Abstract] [Full Text] [Related]
5. Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats. De Ross J; Castilho VM; Brandão ML; Nobre MJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):794-802. PubMed ID: 18281136 [TBL] [Abstract][Full Text] [Related]
6. Psychotropic discontinuation symptoms: a case of withdrawal neuroleptic malignant syndrome. Stonecipher A; Galang R; Black J Gen Hosp Psychiatry; 2006; 28(6):541-3. PubMed ID: 17088172 [TBL] [Abstract][Full Text] [Related]
7. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats. Zhao Y; Weiss F; Zorrilla EP Alcohol Clin Exp Res; 2007 Sep; 31(9):1505-15. PubMed ID: 17760785 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of BR-16A (Mentat), a herbal preparation on alcohol abstinence-induced anxiety and convulsions. Kulkarni SK; Verma A Indian J Exp Biol; 1993 May; 31(5):435-9. PubMed ID: 8359850 [TBL] [Abstract][Full Text] [Related]
9. Anxiogenic effects of cocaine withdrawal in zebrafish. López-Patiño MA; Yu L; Cabral H; Zhdanova IV Physiol Behav; 2008 Jan; 93(1-2):160-71. PubMed ID: 17889042 [TBL] [Abstract][Full Text] [Related]
10. Gamma1- and gamma2-melanocyte stimulating hormones induce central anxiogenic effects and potentiate ethanol withdrawal responses in the elevated plus-maze test in mice. Jansone B; Rumaks J; Dzirkale Z; Pupure J; Svirskis S; Muceniece R; Klusa V Pharmacol Biochem Behav; 2009 Apr; 92(2):267-71. PubMed ID: 19135472 [TBL] [Abstract][Full Text] [Related]
11. Neurological complications of substance abuse. Brust JC Res Publ Assoc Res Nerv Ment Dis; 1992; 70():193-203. PubMed ID: 1535931 [No Abstract] [Full Text] [Related]
12. [Unwanted drug effects of psychotropic drugs in neurologic practice]. Schmidt LG; Schüssler G; Linden M; Müller-Oerlinghausen B Nervenarzt; 1985 Jan; 56(1):19-24. PubMed ID: 2858064 [No Abstract] [Full Text] [Related]
13. Alternative explanations for withdrawal psychosis. Cole JO; Lawrence J Am J Psychiatry; 1984 Sep; 141(9):1129-30. PubMed ID: 6465395 [No Abstract] [Full Text] [Related]
14. Drugs for psychiatric disorders. Med Lett Drugs Ther; 1994 Oct; 36(933):89-96. PubMed ID: 7935156 [No Abstract] [Full Text] [Related]
15. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal. Lal H; Harris CM; Benjamin D; Springfield AC; Bhadra S; Emmett-Oglesby MW J Pharmacol Exp Ther; 1988 Nov; 247(2):508-18. PubMed ID: 3183950 [TBL] [Abstract][Full Text] [Related]
16. Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol. Emmett-Oglesby MW; Mathis DA; Harris CM; Idemudia SO; Lal H J Pharmacol Exp Ther; 1988 Mar; 244(3):892-7. PubMed ID: 3150850 [TBL] [Abstract][Full Text] [Related]